OOIR: Observatory of International Research

Papers

(The TQCC of British Journal of Dermatology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Perineal cutaneous basal cell carcinomas in patients with familial seronegative coeliac disease: report of three cases	260
P06 Functional MDM2 ablation in HK1.ras/fos-Δ5PTEN transgenic mice results in an elevated, p53-mediated block of carcinogenesis that depends upon p53 expression	216
O20 Advanced melanoma is associated with distinct circulating B-cell profiles enriched with immunoregulatory and autoreactive features	174
Editor's Choice – John Ingram – July 2023	84
O11 The human discs large protein (Dlg1) controls connexin 43 (Cx43) plasma membrane localization and gap junctional communication in keratinocytes	77
O16 The novel roles of laminin α3 in epidermal barrier function and metabolism	72
P26 Characterization of skin barrier defects in atopic dermatitis patients using attenuated total reflection Fourier transform infrared spectroscopy	70
O15 Using CRISPR-Cas9 to annotate the TYK2 pathway in psoriasis	70
P08 Dissection of the molecular and cellular heterogeneity of dermal fibroblasts in skin fibrosis	69
O06 Exploring host–microbiome–immune interactions using singular and multispecies inoculations in optimized 3D skin models	68
O19 CYLD cutaneous syndrome tumours demonstrate increased NF-κB signalling and diminished collagen organisation.	65
P15 Surface engineering of novel polydimethylsiloxane composites to attract bacteria: potential to treat chronic infected wounds and reduce antimicrobial resistance	65
Greater understanding about the role of a long non-coding RNA in the development of cutaneous squamous cell carcinoma	61
Dermatology has no walls: a perspective on international exchange	59
Response to ‘The essential role of dermatology publications in enhancing professional diversity, equity and inclusion’	59
Decreased quality of life in people with psoriasis and psoriatic arthritis vs. people with psoriasis alone: data from a national US survey	56
Patient preferences for stratified medicine in psoriasis: a discrete choice experiment*	55
Assessment of treatment response on facial vitiligo, a step forward. But what about the neck?	55
Editor's Choice – John Ingram – January 2024	54
Greater understanding about differences in the long-term course of eczema and their risk factors in children	54
Nemolizumab reduces itch and improves other signs of atopic dermatitis in children aged 6–12 years	54
Comment on ‘Failure of scabies treatment: a systemic review and meta-analysis’	53
Effect of ruxolitinib cream on achievement of VASI50 by body region: Week 52 pooled analysis of the TRuE-V phase 3 studies	52
Patient research priorities in melanoma: a national qualitative interview study	51
320 Study design and interim recruitment into the post-authorization safety study to monitor pregnancy and infant outcomes following administration of dupilumab during planned or unexpected pregnancy	51

Unseen spaces: inverse psoriasis between the toes	48
Expanding the SLURP1 disease spectrum: from Mal de Meleda to palmoplantar keratoderma/progressive symmetric erythrokeratoderma	48
BI11 Cutaneous presentation of Kaposi sarcoma following allogeneic haematopoietic stem cell transplantation for myeloma	47
BI26 Treatment-induced scleroderma in a patient with metastatic melanoma	47
CD04 An unusual case of menorrhagia and an episodic rash	46
BI25 Immunotherapy-associated Sweet syndrome in a patient with metastatic melanoma	46
BI23 Erythrodermic eczematous reactions to immunoglobulins	45
CPC02 Delayed widespread lichenoid drug reaction with radioisotopic response in a patient treated with nivolumab	45
BI20 Generalized pustular psoriasis in a patient receiving pembrolizumab for metastatic lung adenocarcinoma	44
Association of disease characteristics with the temporal sequence of skin and musculoskeletal disease onset in psoriatic arthritis	43
How can we best use scoring scales that can be completed in clinic for assessing improvements in the severity of eczema?	42
利用患者和黑色素瘤组织信息预测癌症向淋巴结扩散的风险 (CP‐GEP 工具)	42
Collecting and summarizing research on people’s views of managing eczema	42
Issue Information	41
Ultraviolet‐related skin cancers distribute differently on the face surface	41
职业与皮肤黑色素瘤之间的联系	41
Skin‐associated lymphoid tissue could be a sign of systemic disease	40
PS04: Burden of treatment in adult patients with atopic dermatitis	39
H11: British Association of Dermatologists’ historical abstracts: an unrivalled resource (284 abstracts by 393 authors)	39
CD14: Contact urticaria caused by the ultraviolet absorber ethylhexyl salicylate in sunscreens	38
Association of atopic dermatitis and autoimmune comorbidities: is it real?	38
PA22: Acrodermatitis enteropathica: how communication skills can help	38
P51: Socioeconomic factors influence severity rather than incidence of dermatoses	36
一项探究特应性皮炎与自身免疫性疾病之间相关性的大型研究发现	36
Response to ‘COVID‐19‐associated multisystem inflammatory syndrome in adults with Kawasaki disease‐like cutaneous manifestations’	35
P29: Routine screening with early‐morning cortisol facilitates identification and improves management of adrenal insufficiency in glucocorticoid‐treated dermatology patients	35
How clinical phenotypes can translate into taxonomy: can we judge atopic dermatitis by its cover?	35
DS29: Indications and outcomes for cutaneous squamous cell carcinomas treated with radiotherapy: a tertiary centre experience	35
Analysis of proteins to help predict which skin cancers might spread to other organs	35
Understanding itch in epidermolysis bullosa (EB)	35
PA14: Emergency paediatric dermatology: a case series of Kasabach–Merritt syndrome	34
PS02: Experiences and understanding of body image dissatisfaction in individuals with a chronic dermatological condition: an interpretative phenomenological analysis	34
P17: Measurement properties of the Cardiff Acne Disability Index (CADI): 28 years of global clinical experience	34
DP04: Utility of human oesophagus as a substrate for indirect immunofluorescence in pemphigus: a descriptive study	33
PS11: Severe suicidal attempt secondary to allergic contact dermatitis in a noncompliant patient	33
DP24: Histology to the rescue for erupting erythematous nodules in a young patient	33
P22: Improving the recognition of dermatological conditions in skin of colour among undergraduate and postgraduate trainees: a cross‐sectional quality‐improvement project	32
Issue Information	32
P73: A pilot study: determining frailty and cognitive impairment in patients with keratinocyte cancer	32
P42: Decreased risk of rheumatic skin diseases in HIV/AIDS	32
皮肤科医生的信心、情绪和经验对银屑病患者护理有哪些影响?一项以使用新疗法阿普米司特为例的访谈研究	32
Looking into the skin with optical coherence tomography	32
CD08: Occupational dermatoses during the second COVID‐19 pandemic wave: an audit of 401 healthcare workers	31
DT04: Pandemic placement: delivering the dermatology undergraduate curriculum at a UK medical school during the COVID‐19 crisis	31
PA23: The use of Biobrane ^® in a paediatric patient with toxic epidermal necrolysis: looking beyond the burn	31
BI10: Skin surveillance in immunocompromised organ transplant recipients: developing a regional protocol	31
GUIDEMAP: an open‐access dermatology guidelines repository	30
How common is palmoplantar pustulosis in Sweden?	30
PD09 (P79): A review of proton pump inhibitor photosensitivity in a tertiary referral photodiagnostic centre	30
Issue Information	30

提供指南以确保对常见皮肤病进行适当护理	30
P52: A virtual multidisciplinary clinic service for the diagnosis and treatment of severe perianal skin disease in hidradenitis suppurativa and Crohn disease	30
一项评估银屑病患者 Tildrakizumab 治疗的长期研究	29
Characterization of patients with advanced basal cell carcinoma progressing while receiving Hedgehog pathway inhibitors	29
Personal ultraviolet radiation exposure can be determined through a simple modelling approach	29
Oral rilzabrutinib as a treatment for patients with pemphigus vulgaris	29
Adcitmer ^® is a potential treatment for Merkel cell carcinoma	29
空气污染会导致皮肤颜色变深	29
News and Notices	29
News and Notices	29
抗银屑病药物在女性中的效果是否优于男性?	28
H06: The high impact of skin disease on British forces in the Crimean War, 1854–56	28
CD12: Hand care: it’s time to take the gloves off	28
儿童和青少年银屑病诊断标准	28
P79: A review of proton pump inhibitor photosensitivity in a tertiary referral photodiagnostic centre	28
P30: Prevalence and treatment patterns of adult atopic dermatitis in the UK Clinical Practice Research Datalink	28
阿利维 A 酸药物的心血管安全性	27
Availability of guidelines to ensure appropriate care for common skin conditions	27
新冠肺炎疫情期间皮肤病变的免疫应答和血管改变	27
RF03: A UK case series of BRCA1‐associated protein‐1 inactivated melanocytic tumours from a tertiary referral centre: a marker for familial melanoma	27
BI29: Case series of vasculitis, iron deficiency anaemia and lymphopenia in patients with scurvy	26
P07: Muir–Torre syndrome associated with treatment‐resistant actinic keratosis and microsatellite instability	26
BT06: Reporting time in two different teledermatology platforms	26
DP23: Melanocytic naevus	26
CD02: Cutaneous reactions to glucose sensors: is the problem stuck with us?	26
化脓性汗腺炎患者对阿达木单抗治疗产生反应的预测性生物标志物	26
Filaggrin gene mutations and eczema in infants	26
efgartigimod 作为天疱疮新疗法的研究	25
Isotretinoin does not contribute to increased neuropsychiatric risk in the overall acne population, but risk management during treatment remains essential	25
The impact of Janus kinase 1 inhibitors on quality of life in patients with hidradenitis suppurativa	25
估计个体日晒量的不同方法	25
Insight into the number of patients diagnosed with basal cell carcinoma in the Netherlands and an estimation of future numbers	25
Response to ‘A clinical and biological review of keratoacanthoma’: reply from authors	25
大疱性表皮松解症妇女妊娠和分娩管理指南	25
BG14: Unilateral multiple facial angiofibromas as a solitary manifestation of tuberous sclerosis	24
BT08: Assessment of three different dermoscopy imaging systems during a fast‐track skin cancer clinic	24
PS08: A prospective noninterventional study to evaluate the psychosocial impact of biological treatment outcomes in patients with moderate‐to‐severe plaque psoriasis in the UK	24
BG10: A case of bilateral metachronous seminomas associated with Birt–Hogg–Dubé syndrome	24
P69: Implementing therapeutic drug monitoring of adalimumab in psoriasis: from theory to practice	24
PA09: Clinical outcomes for paediatric cutaneous lymphoma in a tertiary centre	24
BH08: A rare cause of hair loss in a child	24
PA04: Monitoring mental health in children and young people attending dermatology clinics	23
Orals	23
PA26: Hyper‐IgE syndrome in skin of colour: a retrospective single‐centre observational study	23
DP08: Metastatic cutaneous myoepithelial carcinoma: a case report	23
PA25: Looking beneath the patient’s skin: investigating patient engagement with the clinical psychologist in our teenage and young adult dermatology clinics	23
Reducing the itchiness associated with atopic dermatitis: results from two long‐term nemolizumab studies	23
P62: Melanoma of unknown primary: a case series and review of the literature	23
P52: Opportunities for implementing a patient‐initiated follow‐up pathway in patients with psoriasis completing narrowband ultraviolet B phototherapy	23
P77: Melanosphere culture of BRAF mutant melanoma identifies CD20 as an adjuvant therapeutic target	23
Greater understanding about how melanoma tumours ulcerate and spread	23
PD16: Behaviours, attitudes and the importance of sun safety via an Arduino development kit	22
PA19: An unusual case of sweating: idiopathic localized unilateral hyperhidrosis in a 9‐year‐old and review of the literature	22
P53: Office 365: Microsoft Lists as a tool for a secure online second‐line/systemic drug database	22
Issue Information	22
CD14: Hypersensitivity towards orthopaedic metal implants: can this be prevented with patch testing?	22
DS01: Observational study of surgical‐site infection in ulcerated skin cancers (OASIS)	22
BG06: The phenotypic spectrum of biallelic plectin mutations: findings from the UK epidermolysis bullosa database	21
BT09: Standard of patient‐sent images in teledermatology 2‐week‐wait skin cancer clinics during the COVID‐19 pandemic	21
BT17: Bridging the gap with Pando	21
PA07: Scratching the surface: a review of online misinformation and conspiracy theories in paediatric atopic dermatitis	21
O07: Efficacy of abrocitinib monotherapy in patients with prior exposure to systemic treatments: pooled results from the JADE MONO‐1 and JADE MONO‐2 studies	21
H08: Pemphix to pemphigus vulgaris: the journey to classifying blisters	21
BH06 (P65): Retrospective analysis of the safety and appropriate use of 2,3‐diphenylcyclopropenone in alopecia in a university teaching hospital	21
BH08: A rare and incidental finding of pili multigemini of the back	21
P47: Improving treatment outcomes for leprosy in Pernambuco, Brazil: a qualitative study exploring the experiences and perceptions of retreatment patients and their carers	21
P34: Reduction in the incidence of dupilumab‐induced ocular surface disease by a preventative topical eye treatment regime	21
Results of the HI‐Light Vitiligo Trial: a clinical trial of corticosteroid ointment and home‐based narrowband ultraviolet light for vitiligo	20
DS08: Exploring unmet needs and attitudes to skin self‐examination in melanoma survivors: interim results	20
如何开发白细胞介素‐1 拮抗剂来治疗皮肤疾病?	20
Is there a place for cell therapies in patients with severe psoriasis?	20
Editor’s Choice	20
YouTube as a source of educational information for natural hair	20
PS07: Service planning for delivery of specialized psychology support to medical dermatology: experience of a participatory co‐design approach at a London teaching hospital	20
Guidelines for narrowband ultraviolet B phototherapy	20
BG09: A homozygous intronic mutation in UNC13D in type 3 familial haemophagocytic lymphohistiocytosis: pathogenic insights regarding subcutaneous panniculitis‐like T‐cel	20
Understanding why patients with vitiligo rarely develop skin cancers	20
What proportion of basal and squamous cell skin cancers are not completely excised?	20
H21: Exploring historical treatments for syphilis through the autobiography of Benvenuto Cellini (1500–1571)	20
DS13: Taking it to extremes: expanding the utility of the ‘flip‐flop flap’ in auricular reconstruction	20

Mirikizumab 治疗银屑病的有效性和安全性	19
P39: Where are we with developing diagnostic criteria for skin diseases? Mapping the evidence in 2021	19
P100: Efficacy of current treatments under study in patients with alopecia areata	19
开展健康宣传活动，禁售日光浴床，以减少皮肤癌: 合理利用医疗预算	19
PD01: The VOICE registry: a vitiligo database – our first year	19
P42: Clinical, histopathological and dermatoscopic characterization of eruptive pseudoangioma developing after COVID‐19 vaccination	19
The effectiveness and safety of topical brepocitinib for the treatment of mild-to-moderate atopic dermatitis	19
DP27: Maculopapular cutaneous mastocytosis mimicking seborrhoeic folliculitis	19
Findings from a survey about hidradenitis suppurativa in the Netherlands	19
BI11: Cutaneous Parathyridaria percutanea in a renal transplant patient	19
Editor's Choice	19
PA24: A case of BASCULE (Bier anaemic spots associated with cyanosis and urticaria‐like eruption) syndrome associated with postural hypotension	19
DS01 (P32): An international, prospective cohort study CompAring Non‐absorbable Versus Absorbable sutures for Skin surgery: the CANVAS	19
Seeking a new chair for the UK Dermatology Clinical Trials Network (UK DCTN)	19
BI16: Severe epidermolysis bullosa acquisita in a patient with graft‐versus‐host disease: causal or coincidental?	19
BC06: A photo case of allergic contact dermatitis to red tattoo ink	19
CPC11: Bromoderma in a patient with chronic obstructive pulmonary disease	19
P89: Stability of Psoriasis Area and Severity Index < 2 response to tildrakizumab through 5 years: pooled analyses from reSURFACE 1 and reSURFACE 2 phase III trials	19
Safety of tralokinumab for the treatment of atopic dermatitis	19
一项在一家大型教学医院进行的 5 年皮肤附属器肿瘤研究, 对关联基因诊断提供了启示	18
Experiences of patients resuming life after immunotherapy for metastatic melanoma	18
Blistering skin side-effects associated with checkpoint inhibitor treatment for cancer	18
P18: Prescribing antipsychotics in dermatology: a national survey of clinical experience, physician confidence and training needs	18
窄带紫外线 B 光疗指南	18
Issue Information	18
BT22: Are patients satisfied with video consultations? A survey in a dermatology outpatient setting	18
对化疗所致脱发的更深入了解	18
Living in areas with hard water may increase risk of eczema in adults in the UK	18
Skin reactions to immune checkpoint inhibitors used in cancer treatment	18
筛查对黑色素瘤发病率和活检率的影响	18
银屑病临床实践指南的质量	18
皮肤红斑狼疮治疗指南	17
Possible new oral treatment for hidradenitis suppurativa	17
BT18: Acceptability of artificial intelligence among dermatologists	17
Citric acid treatment of infected venous eczema refractory to conventional treatment: a novel approach	17
扁平苔藓是否与其他疾病存在关联?	17
通过研究免疫检查点受体进一步了解皮肤 T 细胞淋巴瘤的疾病严重性	17
P10: Bullous morphoea with objectively assessed response to mycophenolate mofetil: a case with literature review	17
PA21: Widespread skin loss due to congenital herpes simplex virus 2 diagnosed postmortem	17
进一步了解不同类型的 CD8 ⁺ 皮肤淋巴瘤	17
DS04: Patient anxiety levels do not predict postoperative or intraoperative pain in Mohs micrographic surgery	17
Microbes in the gut relate to melanoma severity	17
PD11: A case series of fixed sunlight eruption following giant hogweed phototoxicity with associated recall phenomenon	17
Mogamulizumab 治疗对 Se'zary 综合征患者益处的新见解	17
BI30: A case of de novo chronic sclerodermoid graft‐versus‐host disease	17
BI09: Rapid and progressive papular facial and truncal rash due to trichodysplasia spinulosa‐associated polyomavirus: a diagnosis to consider in immunosuppressed patients	17
评估系统性硬化症患者手部受累的整体影响的量表	17
西班牙一项猴痘研究的结果	17
PS01 (P18): Prescribing antipsychotics in dermatology: a national survey of clinical experience, physician confidence and training needs	16
BH13: Scarring alopecia affecting a congenital melanocytic naevus in a patient with frontal fibrosing alopecia	16
DP12: An 11‐year mystery	16
Clinical practice guidelines for psoriasis: which ones are the best?	16
Eligibility criteria for programmed death receptor 1 inhibitors vs. real‐world advice: a retrospective analysis of 69 patients with advanced cutaneous squamous cell carcinoma of the head and neck	16
P31: Clinical and chemokine profile in patients with leprosy during multidrug therapy and their healthy contacts: a randomized control trial	16
Measuring ultraviolet exposure to the face in patients with xeroderma pigmentosum	16
P21: Do we need to improve our continuing professional development training for cutaneous T‐cell lymphoma?	16
Editor’s Choice	16
BJD Reviewers January 2021‐ December 2021	16
P57: New order: redesigning referral pathways to improve access for patients from dermatology outpatient waiting lists	16
ED01: Eczema Assessment and Severity Index scoring in skin of colour	15
银屑病皮肤细胞中的小分子 RNA 促进炎症发生	15
P38: Machine learning methods for the prediction of treatment outcome in psoriasis: a systematic review	15
抗药性细菌和皮肤	15
英格兰和威尔士的大疱性表皮松解症	15
CPC09: A contrasting diagnosis: iododerma	15
BH02 (P25): Assessing the clinicophenotypic characteristics and metabolic changes in males with early‐onset androgenetic alopecia and altered hormonal profile: a comparative cross‐sectional study	15
BI31: Scleromyxoedema and iliac vein fibrosis associated unilateral venous ulceration in a case of IgG4 disease	15
P04: Phototherapy to treat a COVID‐19 vaccine reaction	15
PA22: An unusual presentation of a tufted angioma	15
问卷调查青少年斑秃患者的体验以及对其毛发脱落情况的评分	15
P15: Twenty years of the UK Dermatology Clinical Trials Network: past, present and future	15
CD17: Ironing water: an under‐recognized source of contact allergens	15
DS20: Melanoma in situ and lentigo maligna: a need to optimize excision margins	15
BH12: Frontal fibrosing alopecia affecting the glabella and lower forehead without scalp involvement	15
O08: Skin tumours in England 2013–2019: in‐depth reporting of a new consensus classification to improve prospective data extraction and clinical interpretation	14
Recognizing psoriasis in children and adolescents: the DIPSOC study	14
P50: Implementing patient‐initiated follow‐up in dermatology: a local departmental experience	14
P13: Adenoid cystic carcinoma: a rare adnexal neoplasm that uncommonly presents in the skin	14
17th Medical Dermatology Meeting, 13 January 2022	14
H10: A Sweet diagnosis to make: the history of Robert Douglas Sweet and acute febrile neutrophilic dermatosis	14
GIRFT04: Teleconsultations in paediatric dermatology: a UK‐wide clinician survey	14
BH09: Frontal fibrosing alopecia in men: is it any different?	14
PA27: Online misinformation around acne vulgaris: a qualitative review	14
Improved understanding about different types of CD8 ⁺ cutaneous lymphomas	13
How do dermatologists’ personal models inform a patient‐centred approach to management: a qualitative study using the example of prescribing a new treatment (Apremilast)*	13
粒细胞集落刺激因子在化脓性汗腺炎中的作用	13
衡量皮肤鳞状细胞癌治疗方法的成功率	13
中国特应性皮炎患者使用杜匹鲁单抗的研究	13
Issue Information	13
News and Notices	13
Characterization of discontinuation and nonpublication of phase III randomized clinical trials of psoriasis	13
寻常性痤疮给全球患者带来的巨大负担	13
角化棘皮瘤综述	13
BI25: Lessons learnt: our experience of a specialist surveillance dermatology clinic for immunosuppressed patients at a UK tertiary centre	13
使用光学相干断层成像术观察皮肤状况	13